With stigmas changing, more adults are turning to the medicinal benefits of CBD and marijuana to treat eye conditions like cataracts.
“Studies have shown that THC, which is the active ingredient in cannabis, does help lower IOP in the eye for a certain period of time. Dr. Dotson performed various studies, where one study showed intraocular pressure dropping up to 40% using cannabis as a form of medicine.” — Healing the Eye Wellness Center
Affecting almost 25 million Americans, cataracts cloud the eye, reduce vision, dull colors and, when not treated, can cause blindness. According to the World Health Organization (WHO) cataract is the leading cause of blindness globally.
The American Academy of Ophthalmology states that while Americans have treatment options for cataract diseases, many don’t understand something is wrong with their eyes until it’s too late. Slightly more common in women than men, cataracts are a growing issue that is affecting vision and quality of life.
Symptoms of cataracts include:
- Fading color
- Blurred vision
- Problems with lights “glaring”
- Poor night vision
The Barnet Dulaney Perkins Eye Center explains that while age is the primary cause of cataract-related issues diseases, such as diabetes, medications like steroids can increase the risk of developing cataracts later in life.
More Americans than ever-growing risk of cataract-related eye diseases
According to the National Eye Institute, “The risk of cataract increases with each decade of life starting around age 40. By age 75, half of white Americans have cataract diseases.”
By 2050, the National Eye Institute believes cataract numbers will double from 24.4 million adults to 50 million adults experiencing cataract issues. The data suggests that those most at risk of a rapid increase are Hispanic Americans.
Continue reading this article on The Fresh Toast.
Benzinga's Related Links:
- All You Need To Know About Canopy's New Online CBD Marketplace
- Cannabinoid Activation And The Metabolism: What Cannabis Consumers Need To Know
photo by jasongillman via Pixabay
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.